Need to have world class regulatory framework, says Nadda at review meeting

CDSCO has been asked to draw a roadmap with timelines for achieving global standards in its mandated activities

JP Nadda, Nadda
Union Health Minister J P Nadda (Photo: PTI)
Sanket Koul New Delhi
2 min read Last Updated : Jul 17 2024 | 9:33 PM IST
Union Health Minister J P Nadda on Wednesday asked officials to stress the need to develop world-class regulatory systems and ensure transparency of procedures at a high-level review meeting on regulations for drugs and cosmetics.

“For India to match our global reputation as the ‘Pharmacy of the World’, we need to have a world-class regulatory framework that matches our scale of operations and international expectations,” Nadda said in the meeting.

Speaking on the need for transparent regulatory procedures, Nadda said that both the industry and the drug regulatory bodies should work with the highest principles of transparency to ensure that the products manufactured and sold by India meet the highest indices of global quality standards.

The Central Drug Standards Control Organisation (CDSCO) has been asked to draw a roadmap with timelines for achieving global standards in its mandated activities.

The minister added that upscaling to good manufacturing practices (GMP) needs to be systems-based, focusing on the highest standards of uniformity, technical upgradation, and a futuristic approach.

This comes as the government started working on the proper implementation of the revised Schedule M, which includes GMP guidelines to ensure the manufacturing of quality drugs.

Some of the major changes introduced in the revised Schedule M include the introduction of a pharmaceutical quality system (PQS), quality risk management (QRM), product quality review (PQR), qualification and validation of equipment, and a computerised storage system for all drug products.

Nadda also stated that it is important for CDSCO to be in continuous dialogue with the drugs and medical devices industry to understand their issues and support them in fulfilling the expectations of quality standards.

“Our focus should be on developing mechanisms that ensure ease of doing business for the drugs industry within the regulatory requirements. For this, CDSCO needs to be a user-friendly organisation with state-of-the-art facilities matching global standards,” Nadda stated in the meeting.

Noting that the states are an integral part of the regulatory value chain, Nadda asked officials to work in tandem with the state regulatory bodies to enhance their skills and capacities and also encourage them to align with the quality standards of the central government.
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :Jagat Prakash NaddaHealth Ministry

First Published: Jul 17 2024 | 9:16 PM IST

Next Story